Logo image of CLS.CA

CELESTICA INC (CLS.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:CLS - CA15101Q2071 - Common Stock

406.01 CAD
-4.03 (-0.98%)
Last: 12/31/2025, 7:00:00 PM
Fundamental Rating

7

Overall CLS gets a fundamental rating of 7 out of 10. We evaluated CLS against 14 industry peers in the Electronic Equipment, Instruments & Components industry. CLS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CLS is growing strongly while it is still valued neutral. This is a good combination! These ratings would make CLS suitable for growth and quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CLS had positive earnings in the past year.
In the past year CLS had a positive cash flow from operations.
Each year in the past 5 years CLS has been profitable.
Each year in the past 5 years CLS had a positive operating cash flow.
CLS.CA Yearly Net Income VS EBIT VS OCF VS FCFCLS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

The Return On Assets of CLS (10.85%) is better than 100.00% of its industry peers.
Looking at the Return On Equity, with a value of 35.33%, CLS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
CLS's Return On Invested Capital of 21.33% is amongst the best of the industry. CLS outperforms 100.00% of its industry peers.
CLS had an Average Return On Invested Capital over the past 3 years of 11.43%. This is in line with the industry average of 9.56%.
The last Return On Invested Capital (21.33%) for CLS is above the 3 year average (11.43%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.85%
ROE 35.33%
ROIC 21.33%
ROA(3y)4.63%
ROA(5y)3.55%
ROE(3y)15.02%
ROE(5y)11.3%
ROIC(3y)11.43%
ROIC(5y)8.93%
CLS.CA Yearly ROA, ROE, ROICCLS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

With a decent Profit Margin value of 6.35%, CLS is doing good in the industry, outperforming 78.57% of the companies in the same industry.
In the last couple of years the Profit Margin of CLS has grown nicely.
CLS has a Operating Margin of 7.33%. This is in the better half of the industry: CLS outperforms 78.57% of its industry peers.
CLS's Operating Margin has improved in the last couple of years.
The Gross Margin of CLS (12.04%) is worse than 85.71% of its industry peers.
CLS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.33%
PM (TTM) 6.35%
GM 12.04%
OM growth 3Y24.27%
OM growth 5Y29.03%
PM growth 3Y34%
PM growth 5Y30.13%
GM growth 3Y8.03%
GM growth 5Y10.39%
CLS.CA Yearly Profit, Operating, Gross MarginsCLS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CLS is creating value.
CLS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CLS has less shares outstanding
CLS has a worse debt/assets ratio than last year.
CLS.CA Yearly Shares OutstandingCLS.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CLS.CA Yearly Total Debt VS Total AssetsCLS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

CLS has an Altman-Z score of 6.92. This indicates that CLS is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CLS (6.92) is better than 64.29% of its industry peers.
CLS has a debt to FCF ratio of 1.97. This is a very positive value and a sign of high solvency as it would only need 1.97 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.97, CLS belongs to the top of the industry, outperforming 92.86% of the companies in the same industry.
A Debt/Equity ratio of 0.37 indicates that CLS is not too dependend on debt financing.
CLS's Debt to Equity ratio of 0.37 is on the low side compared to the rest of the industry. CLS is outperformed by 64.29% of its industry peers.
Although CLS does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 1.97
Altman-Z 6.92
ROIC/WACC2.62
WACC8.13%
CLS.CA Yearly LT Debt VS Equity VS FCFCLS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.47 indicates that CLS should not have too much problems paying its short term obligations.
With a Current ratio value of 1.47, CLS perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
CLS has a Quick Ratio of 1.47. This is a bad value and indicates that CLS is not financially healthy enough and could expect problems in meeting its short term obligations.
CLS's Quick ratio of 0.88 is in line compared to the rest of the industry. CLS outperforms 42.86% of its industry peers.
CLS does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 0.88
CLS.CA Yearly Current Assets VS Current LiabilitesCLS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

9

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 47.90% over the past year.
The Earnings Per Share has been growing by 48.11% on average over the past years. This is a very strong growth
Looking at the last year, CLS shows a very strong growth in Revenue. The Revenue has grown by 22.09%.
Measured over the past years, CLS shows a quite strong growth in Revenue. The Revenue has been growing by 10.38% on average per year.
EPS 1Y (TTM)47.9%
EPS 3Y44.1%
EPS 5Y48.11%
EPS Q2Q%51.92%
Revenue 1Y (TTM)22.09%
Revenue growth 3Y19.63%
Revenue growth 5Y10.38%
Sales Q2Q%27.79%

3.2 Future

The Earnings Per Share is expected to grow by 38.14% on average over the next years. This is a very strong growth
Based on estimates for the next years, CLS will show a very strong growth in Revenue. The Revenue will grow by 27.74% on average per year.
EPS Next Y53.05%
EPS Next 2Y46.37%
EPS Next 3Y43.28%
EPS Next 5Y38.14%
Revenue Next Year26.52%
Revenue Next 2Y29.69%
Revenue Next 3Y30.76%
Revenue Next 5Y27.74%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLS.CA Yearly Revenue VS EstimatesCLS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B 25B
CLS.CA Yearly EPS VS EstimatesCLS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10

5

4. Valuation

4.1 Price/Earnings Ratio

CLS is valuated quite expensively with a Price/Earnings ratio of 56.16.
Based on the Price/Earnings ratio, CLS is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
CLS is valuated expensively when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 35.31 indicates a quite expensive valuation of CLS.
Based on the Price/Forward Earnings ratio, CLS is valued cheaply inside the industry as 92.86% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.13, CLS is valued quite expensively.
Industry RankSector Rank
PE 56.16
Fwd PE 35.31
CLS.CA Price Earnings VS Forward Price EarningsCLS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLS is valued a bit cheaper than the industry average as 78.57% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CLS is valued a bit cheaper than 71.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 85.67
EV/EBITDA 34.96
CLS.CA Per share dataCLS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

CLS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of CLS may justify a higher PE ratio.
A more expensive valuation may be justified as CLS's earnings are expected to grow with 43.27% in the coming years.
PEG (NY)1.06
PEG (5Y)1.17
EPS Next 2Y46.37%
EPS Next 3Y43.28%

0

5. Dividend

5.1 Amount

CLS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CELESTICA INC

TSX:CLS (12/31/2025, 7:00:00 PM)

406.01

-4.03 (-0.98%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)10-27 2025-10-27/amc
Earnings (Next)01-27 2026-01-27/amc
Inst Owners73.88%
Inst Owner ChangeN/A
Ins Owners0.52%
Ins Owner ChangeN/A
Market Cap46.71B
Revenue(TTM)11.28B
Net Income(TTM)716.70M
Analysts81.11
Price Target347.67 (-14.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.15%
Min EPS beat(2)6.6%
Max EPS beat(2)11.71%
EPS beat(4)4
Avg EPS beat(4)6.73%
Min EPS beat(4)1.95%
Max EPS beat(4)11.71%
EPS beat(8)8
Avg EPS beat(8)9.68%
EPS beat(12)12
Avg EPS beat(12)8.66%
EPS beat(16)16
Avg EPS beat(16)9.16%
Revenue beat(2)2
Avg Revenue beat(2)6.2%
Min Revenue beat(2)5%
Max Revenue beat(2)7.4%
Revenue beat(4)3
Avg Revenue beat(4)3.54%
Min Revenue beat(4)-0.75%
Max Revenue beat(4)7.4%
Revenue beat(8)7
Avg Revenue beat(8)3.49%
Revenue beat(12)11
Avg Revenue beat(12)3.14%
Revenue beat(16)14
Avg Revenue beat(16)3.37%
PT rev (1m)0%
PT rev (3m)54.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)19.76%
EPS NY rev (1m)2.21%
EPS NY rev (3m)8.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)14.35%
Revenue NY rev (1m)1.67%
Revenue NY rev (3m)5.83%
Valuation
Industry RankSector Rank
PE 56.16
Fwd PE 35.31
P/S 3.02
P/FCF 85.67
P/OCF 61.77
P/B 16.82
P/tB 24.15
EV/EBITDA 34.96
EPS(TTM)7.23
EY1.78%
EPS(NY)11.5
Fwd EY2.83%
FCF(TTM)4.74
FCFY1.17%
OCF(TTM)6.57
OCFY1.62%
SpS134.27
BVpS24.14
TBVpS16.81
PEG (NY)1.06
PEG (5Y)1.17
Graham Number62.67
Profitability
Industry RankSector Rank
ROA 10.85%
ROE 35.33%
ROCE 26.62%
ROIC 21.33%
ROICexc 23.67%
ROICexgc 30.35%
OM 7.33%
PM (TTM) 6.35%
GM 12.04%
FCFM 3.53%
ROA(3y)4.63%
ROA(5y)3.55%
ROE(3y)15.02%
ROE(5y)11.3%
ROIC(3y)11.43%
ROIC(5y)8.93%
ROICexc(3y)13.32%
ROICexc(5y)10.55%
ROICexgc(3y)18.44%
ROICexgc(5y)14.81%
ROCE(3y)14.26%
ROCE(5y)11.14%
ROICexgc growth 3Y31.4%
ROICexgc growth 5Y28.76%
ROICexc growth 3Y37.65%
ROICexc growth 5Y29.81%
OM growth 3Y24.27%
OM growth 5Y29.03%
PM growth 3Y34%
PM growth 5Y30.13%
GM growth 3Y8.03%
GM growth 5Y10.39%
F-Score7
Asset Turnover1.71
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 1.97
Debt/EBITDA 0.76
Cap/Depr 94.54%
Cap/Sales 1.37%
Interest Coverage 15.59
Cash Conversion 55.82%
Profit Quality 55.56%
Current Ratio 1.47
Quick Ratio 0.88
Altman-Z 6.92
F-Score7
WACC8.13%
ROIC/WACC2.62
Cap/Depr(3y)94.48%
Cap/Depr(5y)73.42%
Cap/Sales(3y)1.62%
Cap/Sales(5y)1.34%
Profit Quality(3y)94.3%
Profit Quality(5y)151.44%
High Growth Momentum
Growth
EPS 1Y (TTM)47.9%
EPS 3Y44.1%
EPS 5Y48.11%
EPS Q2Q%51.92%
EPS Next Y53.05%
EPS Next 2Y46.37%
EPS Next 3Y43.28%
EPS Next 5Y38.14%
Revenue 1Y (TTM)22.09%
Revenue growth 3Y19.63%
Revenue growth 5Y10.38%
Sales Q2Q%27.79%
Revenue Next Year26.52%
Revenue Next 2Y29.69%
Revenue Next 3Y30.76%
Revenue Next 5Y27.74%
EBIT growth 1Y62.33%
EBIT growth 3Y48.65%
EBIT growth 5Y42.42%
EBIT Next Year67.79%
EBIT Next 3Y43.39%
EBIT Next 5Y38.43%
FCF growth 1Y48.75%
FCF growth 3Y20.17%
FCF growth 5Y2.76%
OCF growth 1Y40.82%
OCF growth 3Y27.84%
OCF growth 5Y6.55%

CELESTICA INC / CLS.CA FAQ

Can you provide the ChartMill fundamental rating for CELESTICA INC?

ChartMill assigns a fundamental rating of 7 / 10 to CLS.CA.


What is the valuation status of CELESTICA INC (CLS.CA) stock?

ChartMill assigns a valuation rating of 5 / 10 to CELESTICA INC (CLS.CA). This can be considered as Fairly Valued.


What is the profitability of CLS stock?

CELESTICA INC (CLS.CA) has a profitability rating of 8 / 10.


What is the valuation of CELESTICA INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CELESTICA INC (CLS.CA) is 56.16 and the Price/Book (PB) ratio is 16.82.


How financially healthy is CELESTICA INC?

The financial health rating of CELESTICA INC (CLS.CA) is 8 / 10.